James Luu

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial

2021 | 3. lékařská fakulta, Lékařská fakulta v Hradci Králové

Publikace